You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 124 No. 10, October 1989 TABLE OF CONTENTS
  Archives
  •  Online Features
  PAPERS READ BEFORE THE 60TH ANNUAL MEETING OF THE PACIFIC COAST SURGICAL ASSOCIATION, VANCOUVER, CANADA, FEBRUARY 22, 1989
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (29)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Heart Transplantation During the First 12 Years of Life

Leonard L. Bailey, MD; Michael Wood, MD; Anees Razzouk, MD; Glen Van Arsdell, MD; Steven Gundry, MD

Arch Surg. 1989;124(10):1221-1226.


Abstract

• Since November 1985, forty-four heart transplants have been accomplished in 43 infants and children younger than 12 years of age. Indications for transplantation included structural heart disease (31 patients), idiopathic or viral cardiomyopathy (10 patients), and combined structural and myopathic disease (2 patients). Postoperative recipient surveillance was achieved noninvasively during the first year of life; endomyocardial biopsy was employed in children. Maintenance immunosuppression included cyclosporine and azathioprine therapy during the first year after transplantation in young infants, graduating to cyclosporine therapy alone beyond the first year. Azathioprine therapy was continued indefinitely in children. There have been 5 perioperative deaths and 1 late death in this series of recipients. Overall survival was 86%. Growth, development, and psychosocial adjustments generally have been excellent. Donor heart growth has been normal. Coronary artery disease has not yet been observed. Our findings indicate that heart transplantation seems to be effective therapy for selected incurable pediatric cardiac diseases.

(Arch Surg. 1989;124:1221-1226)



Author Affiliations

The Loma Linda University Pediatric Heart Transplant Group

From the Division of Cardiothoracic Surgery, Department of Surgery, Loma Linda (Calif) University Medical Center.


Footnotes

Accepted for publication June 12, 1989.

Read before the 60th Annual Meeting of the Pacific Coast Surgical Association, Vancouver, Canada, February 22, 1989.

Reprint requests to the Division of Cardiothoracic Surgery, Loma Linda University Medical Center, Loma Linda, CA 92354 (Dr Bailey).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The adventure of cardiac surgery
Murtra
Eur. J. Cardiothorac. Surg. 2002;21:167-180.
FULL TEXT  

Thoracic Organ Transplantation in Children: The State of Heart, Heart-Lung, and Lung Transplantation
Moodie and Stillwell
CLIN PEDIATR 1993;32:322-328.
ABSTRACT  

Ethical Considerations in Listing Fetuses as Candidates for Neonatal Heart Transplantation
Michaels et al.
JAMA 1993;269:401-403.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1989 American Medical Association. All Rights Reserved.